SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing strong momentum, largely driven by a perceived memory supercycle fueled by insatiable AI demand and recent positive sector earnings from peers. Community sentiment highlights $MU's strategic investments, low forward valuation compared to other AI plays, and its critical role in high-bandwidth memory, leading many to anticipate significant growth.

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics ($RR) is experiencing a surge in attention following its collaboration with Microsoft's AI Co-Innovation Labs, integrating Azure-powered agentic AI into its robotics portfolio. This partnership is driving significant community excitement, with many seeing it as a major validation in the booming AI and robotics sector and anticipating a potential multi-day rally and short squeeze. Despite some calls for caution regarding profit-taking, market sentiment reflects strong bullishness for future growth.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as the broader market achieves new all-time highs, propelled by strong momentum in mega-cap tech stocks and positive news surrounding potential NVIDIA-Intel collaboration. Community sentiment is sharply divided, with bulls celebrating an "easy money" environment while bears warn of an "artificial pump" and an impending "deep pullback" ahead of crucial Big Tech earnings and the Federal Reserve's policy meeting.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold reaches unprecedented new all-time highs, propelled by widespread concerns over a weakening US dollar and escalating geopolitical risks. The community is intensely debating if this surge signifies a fundamental shift towards precious metals as a hedge against fiat currency debasement and systemic financial warnings, or if it represents an unsustainable, speculative rally. Investors are closely monitoring its trajectory, with many pointing to central bank accumulation and broader economic anxieties as key drivers.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending with widespread community speculation about an impending major partnership, particularly with Amazon, anticipated to coincide with its upcoming earnings report. This excitement builds on IREN's significant rally, driven by its strategic expansion into high-demand AI infrastructure and data center services, positioning it as a key player in the sector amidst fluctuating market conditions.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is trending following robust earnings that exceeded expectations, fueled by surging demand for AI-driven data storage solutions. The company's booked high-capacity product capacity through calendar year 2027 and orders for 2028 are igniting community excitement, reinforcing the broader memory supercycle narrative. While many celebrate strong performance and future outlook, some investors express caution, questioning valuation and anticipating a potential pullback after the significant run.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

The semiconductor sector is experiencing a powerful surge, primarily driven by robust Artificial Intelligence (AI) demand and favorable developments from key chipmakers. Traders are actively discussing SOXL's remarkable upward trajectory, with many anticipating further significant gains while a cautious few note its extended run. This strong momentum highlights the market's intense focus on tech-led growth, prompting conversations about whether the current cycle will surpass previous peaks.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending due to a government proposal for future Medicare Advantage payment rates, which were significantly lower than market expectations, triggering a broad sell-off across the healthcare insurance sector. The community is sharply divided, with many viewing this as an overreaction and a "buy the dip" opportunity, while others anticipate continued pressure on profitability amid regulatory uncertainty. This policy shift has broader implications for the managed care industry's outlook.

Virtuix Holdings Inc. - Ordinary Shares - Class A

Virtuix Holdings Inc. (VTIX) is a top trending stock following its recent debut on Nasdaq, sparking significant community interest due to extreme intraday volatility and multiple trading halts. Investors are actively discussing its potential for further explosive moves, especially in after-hours trading, driven by its gaming and AI-driven narrative.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is seeing heightened activity following its recent earnings report, where strong forward guidance for the upcoming quarter is overshadowing some reported performance misses. This unexpected optimism is fueling community discussion, with many viewing it as a positive indicator for the broader semiconductor sector and a sign that TXN's long-term capital investments are beginning to resonate with investors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Recommendation of "Moderate Buy" by Brokerages

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com...

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell?

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell...

What is HC Wainwright's Estimate for ESPR FY2025 Earnings?

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Stock analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Esperion Therapeutics in a note issued to investors...

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why...

Esperion Therapeutics (NASDAQ:ESPR) Sets New 12-Month High - Here's Why

Esperion Therapeutics (NASDAQ:ESPR) Reaches New 1-Year High - Should You Buy...

Esperion Therapeutics (NASDAQ:ESPR) Upgraded by Wall Street Zen to "Buy" Rating

Wall Street Zen upgraded shares of Esperion Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Up - What's Next?

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Up - What's Next...

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 4.8% - Time to Sell?

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 4.8% - Here's What Happened...

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) have earned an average rating of "Moderate Buy" from the eight research firms that are covering the stock, MarketBeat reports...

Esperion Therapeutics (NASDAQ:ESPR) Hits New 52-Week High - Time to Buy?

Esperion Therapeutics (NASDAQ:ESPR) Reaches New 1-Year High - What's Next...

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Current Price	$3.42
Prev Close	$3.34
Open	$3.34
Dividend Yield	0.00%
50-Day Moving Average	$3.55
Beta	1.15
Avg. Volume	5.13M
PE Ratio	-6.38

52-Week High	$4.18
52-Week Low	$0.6925
Market Capitalization	$805.13M
EPS (Annual)	-$0.2764
Price to Book	-1.56
Revenue Per Employee	$1.09M
Enterprise Value/EBITDA	N/A

ESPR
Esperion Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ESPR News

ESPREsperion Therapeutics Inc.